Mark Bower
Impact in
- Oncology top 0.2%
- Viral-associated cancers and disorders
- Polyomavirus and related diseases
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 182
- Viral-associated cancers and disorders 149
- Polyomavirus and related diseases 15
-
- Lymphoma Diagnosis and Treatment 67
- Co-authors
- Mark Nelson (93 shared papers)Justin Stebbing (93 shared papers)Brian Gazzard (77 shared papers)Sundhiya Mandalia (32 shared papers)E.S. Newlands (22 shared papers)Tom Powles (27 shared papers)Gordon Rustin (12 shared papers)Tom Newsom‐Davis (16 shared papers)
- Journals
- AIDS (32 papers)Journal of Clinical Oncology (22 papers)Blood (18 papers)European Journal of Cancer (13 papers)British Journal of Cancer (12 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Mark Bower
337 papers receiving 11.6k citations
Mark Bower's Hit Papers
Peers
Comparison fields: 5 of 148
- Oncology 5.9k
- Pathology and Forensic Medicine 2.3k
- Virology 575
- Genetics 905
- Infectious Diseases 1.5k
Countries citing papers authored by Mark Bower
This map shows the geographic impact of Mark Bower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bower more than expected).
Fields of papers citing papers by Mark Bower
This network shows the impact of papers produced by Mark Bower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bower. The network helps show where Mark Bower may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bower, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 346 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Kaposi sarcoma Hit paper breakdown → | 2019 | 439 |
| 2 | 2005 | 302 | |
| 3 | 2008 | 280 | |
| 4 | 2017 | 257 | |
| 5 | 1997 | 251 | |
| 6 | Phase I trial of temozolomide using an extended continuous oral schedule. | 1998 | 239 |
| 7 | 1997 | 198 | |
| 8 | 2005 | 191 | |
| 9 | 2008 | 179 | |
| 10 | 2010 | 172 | |
| 11 | 2000 | 169 | |
| 12 | 2004 | 160 | |
| 13 | 2004 | 146 | |
| 14 | 2007 | 143 | |
| 15 | 1999 | 139 | |
| 16 | 2010 | 138 | |
| 17 | 1996 | 138 | |
| 18 | 2003 | 136 | |
| 19 | 2011 | 133 | |
| 20 | 2012 | 131 |
About Mark Bower
Mark Bower is a scholar working on Oncology, Pathology and Forensic Medicine, Epidemiology, Infectious Diseases and Surgery, having authored 346 papers that have together received 12.2k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (149 papers), Lymphoma Diagnosis and Treatment (67 papers), HIV/AIDS drug development and treatment (34 papers), Cytomegalovirus and herpesvirus research (29 papers), HIV Research and Treatment (26 papers), CNS Lymphoma Diagnosis and Treatment (18 papers), Immune Cell Function and Interaction (17 papers) and Polyomavirus and related diseases (15 papers). The work is most often cited by research in Oncology (5.9k citations), Pathology and Forensic Medicine (2.3k citations), Virology (575 citations), Genetics (905 citations) and Infectious Diseases (1.5k citations). Mark Bower has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Mark Nelson, Justin Stebbing, Brian Gazzard, Sundhiya Mandalia, E.S. Newlands, Tom Powles, Gordon Rustin, Tom Newsom‐Davis, L. Holden and Ashita Waterston. Their work appears in journals such as AIDS, Journal of Clinical Oncology, Blood, European Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.